MicroRNA-212-3p inhibits the Proliferation and Invasion of Human Hepatocellular Carcinoma Cells by Suppressing CTGF expression

[1]  L. D. White,et al.  EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells , 2017, Nature Communications.

[2]  Chang Hoon Shin,et al.  SRSF3‐regulated miR‐132/212 controls cell migration and invasion by targeting YAP1 , 2017, Experimental cell research.

[3]  Zhankui Jia,et al.  MicroRNA-212 inhibits the proliferation, migration and invasion of renal cell carcinoma by targeting X-linked inhibitor of apoptosis protein (XIAP) , 2017, Oncotarget.

[4]  Yi Sun,et al.  hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma , 2017, International journal of molecular medicine.

[5]  Xin Hu,et al.  Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer , 2017, Scientific Reports.

[6]  Liangfang Shen,et al.  Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma , 2016, Oncotarget.

[7]  F. Liu,et al.  MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma. , 2017, American journal of translational research.

[8]  Shaohua Zhang,et al.  MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4. , 2017, Oncology reports.

[9]  S. Shany,et al.  Vitamin D and Myofibroblasts in Fibrosis and Cancer: At Cross-purposes with TGF-β/SMAD Signaling. , 2016, Anticancer research.

[10]  L. Lau.  Cell surface receptors for CCN proteins , 2016, Journal of Cell Communication and Signaling.

[11]  Chinyi Chu,et al.  MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors , 2015, Hepatology.

[12]  Céline Lefebvre,et al.  Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles. , 2015, European journal of cancer.

[13]  Qiongjing Yuan,et al.  Epigenetic repression of Krüppel-like factor 4 through Dnmt1 contributes to EMT in renal fibrosis , 2015, International journal of molecular medicine.

[14]  Kwan-Kyu Park,et al.  Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition. , 2014, World journal of hepatology.

[15]  W. Jia,et al.  MicroRNA‐195 Suppresses Angiogenesis and Metastasis of Hepatocellular Carcinoma by Inhibiting the Expression of VEGF, VAV2, and CDC42 , 2013, Hepatology.

[16]  Y. Yen,et al.  MicroRNA‐657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin‐like enhancer protein 1 through nuclear factor kappa B pathways , 2013, Hepatology.

[17]  R. Simpson,et al.  Contribution of cells undergoing epithelial-mesenchymal transition to the tumour microenvironment. , 2013, Journal of proteomics.

[18]  Min Liu,et al.  miR-490-3p Modulates Cell Growth and Epithelial to Mesenchymal Transition of Hepatocellular Carcinoma Cells by Targeting Endoplasmic Reticulum-Golgi Intermediate Compartment Protein 3 (ERGIC3)* , 2012, The Journal of Biological Chemistry.

[19]  P. Jung,et al.  Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. , 2012, Cancer cell.

[20]  R. Finn.  Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR Inhibition , 2012, Liver Cancer.

[21]  F. Sotgia,et al.  CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth , 2012, Cell cycle.

[22]  D. Sahani,et al.  HCC and angiogenesis: possible targets and future directions , 2011, Nature Reviews Clinical Oncology.

[23]  M. Kew.  Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. , 2010, Pathologie-biologie.

[24]  Jeffrey M. Rosen,et al.  Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[25]  S. Alahari,et al.  miRNA control of tumor cell invasion and metastasis , 2010, International journal of cancer.

[26]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[27]  Qian Wang,et al.  Bead‐based microarray analysis of microRNA expression in hepatocellular carcinoma: miR‐338 is downregulated , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[28]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[29]  M. Nieto,et al.  Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. , 2009, The Journal of clinical investigation.

[30]  R. Bjerkvig,et al.  Lymphangiogenesis in colorectal cancer—Prognostic and therapeutic aspects , 2007, International journal of cancer.

[31]  T. Okanoue,et al.  Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.

[32]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[33]  G. Berx,et al.  SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell–cell junctions , 2005, Nucleic acids research.